Rechercher | DOGLALA

Akash Motar Ajouter une nouvelle offre d'emploi Autre
2025-12-11 14:17:09 -

Anal Cancer Drug Market: Chemotherapy, Targeted Therapies, and Immunotherapy Treatment Strategies in Oncology
"Executive Summary Anal Cancer Drug Market Research: Share and Size Intelligence The global anal cancer drug market size was valued at USD 401.57 million in 2024 and is projected to reach USD 1,199.82 million by 2032, with a CAGR of 13.80 % during the forecast period of 2025 to 2032. Best-practice models and research methodologies have been employed in the reliable Anal Cancer Drug Market...

0 Commentaires 0 Parts 113 Vue

Connectez-vous pour aimer, partager et commenter!
Univ Datos Ajouter une nouvelle offre d'emploi Autre
2025-12-19 11:51:50 -

Cancer Immunotherapy Market Size, Demands, Growth, Forecast & Analysis 2032 | UnivDatos
The Cancer Immunotherapy Market was valued at approximately USD 120 billion in 2023 and is expected to grow at a substantial CAGR of around 10% during the forecast period (2024-2032) Since the early 2000s, cancer immunotherapy has emerged as one of the most transformative advancements in oncology, fundamentally changing how cancer is treated. Unlike conventional therapies, immunotherapy...

0 Commentaires 0 Parts 83 Vue

Connectez-vous pour aimer, partager et commenter!
Sanket Khot Ajouter une nouvelle offre d'emploi News
2025-12-11 18:27:23 -

Cell-Based Immunotherapy Market Size, Share and Forecast Analysis Report 2028
The Global Cell-Based Immunotherapy Market is harnessing the body's own defenses to combat cancer, offering a paradigm shift from toxic chemotherapies to precision-engineered treatments. Cell-based immunotherapy utilizes stem cells and immune cells like T-cells to target tumors selectively, replenishing specialized cells and boosting the immune response against malignancies. As...

0 Commentaires 0 Parts 99 Vue

Connectez-vous pour aimer, partager et commenter!
Komal Galande Ajouter une nouvelle offre d'emploi News
2025-12-09 05:57:24 -

Can Personalized Cancer Vaccines Redefine Targeted Oncology Treatments?
"In-Depth Study on Executive Summary Personalized Cancer Vaccines Market Size and Share Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The world class...

0 Commentaires 0 Parts 377 Vue

Connectez-vous pour aimer, partager et commenter!
Ksh Dbmr Ajouter une nouvelle offre d'emploi News
2025-11-21 08:05:16 -

How are new therapies reshaping the urothelial cancer drugs market?
Competitive Analysis of Executive Summary Urothelial Cancer Drugs Market Size and Share CAGR Value The global Urothelial Cancer Drugs market size was valued at USD 1.44 billion in 2024 and is expected to reach USD 2.80 billion by 2032, at a CAGR of 8.7% during the forecast period Keeping into consideration the customer requirement, an influential Urothelial Cancer Drugs...

0 Commentaires 0 Parts 213 Vue

Connectez-vous pour aimer, partager et commenter!
Aryan Mhatre Ajouter une nouvelle offre d'emploi Lifestyle
2025-12-16 10:35:01 -

Pinta Treatment Market Leaders: Growth, Share, Value, Size, and Scope
"Executive Summary Pinta Treatment Market Size and Share: Global Industry Snapshot The global pinta treatment market size was valued at USD 382.50 Million in 2025 and is expected to reach USD 578.17 Million by 2033, at a CAGR of 5.30% during the forecast period Each of the topics covered in the Pinta Treatment report is studied very well to get a clear...

0 Commentaires 0 Parts 4KB Vue

Connectez-vous pour aimer, partager et commenter!
Ksh Dbmr Ajouter une nouvelle offre d'emploi News
2025-11-21 08:17:05 -

What breakthroughs are propelling the thyroid cancer drug market forward?
Executive Summary Thyroid Cancer Drug Market Value, Size, Share and Projections CAGR Value Data Bridge Market Research analyses that the global thyroid cancer drug market which was USD 712.56 million in 2022, is expected to reach USD 2,505.56 million by 2030, and is expected to undergo a CAGR of 17.2% during the forecast period 2023-2030. The world class Thyroid Cancer Drug...

0 Commentaires 0 Parts 233 Vue

Connectez-vous pour aimer, partager et commenter!